These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 25367836

  • 1. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
    Madane RG, Mahajan HS.
    Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
    How CW, Rasedee A, Manickam S, Rosli R.
    Colloids Surf B Biointerfaces; 2013 Dec 01; 112():393-9. PubMed ID: 24036474
    [Abstract] [Full Text] [Related]

  • 3. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F, Asghar S, Xu Y, Wang J, Jin X, Wang Z, Wang J, Ping Q, Zhou J, Xiao Y.
    Int J Pharm; 2016 Jun 15; 506(1-2):46-56. PubMed ID: 27094357
    [Abstract] [Full Text] [Related]

  • 4. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y, Pan L, Jiang M, Li D, Jin L.
    Drug Deliv; 2016 May 15; 23(4):1383-92. PubMed ID: 26066035
    [Abstract] [Full Text] [Related]

  • 5. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
    Jojo GM, Kuppusamy G, De A, Karri VVSNR.
    Drug Dev Ind Pharm; 2019 Jul 15; 45(7):1061-1072. PubMed ID: 30922126
    [Abstract] [Full Text] [Related]

  • 6. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J, Zhang L, Chen Z, Mao G, Gao Z, Lai X, Zhu X, Zhu J.
    Drug Deliv; 2016 Nov 15; 23(9):3408-3416. PubMed ID: 27181462
    [Abstract] [Full Text] [Related]

  • 7. Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.
    Bondì ML, Emma MR, Botto C, Augello G, Azzolina A, Di Gaudio F, Craparo EF, Cavallaro G, Bachvarov D, Cervello M.
    J Agric Food Chem; 2017 Feb 22; 65(7):1342-1352. PubMed ID: 28111949
    [Abstract] [Full Text] [Related]

  • 8. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H, Salimi M, Sadighian S, Rostamizadeh K, Ramazani A.
    Curr Drug Deliv; 2019 Feb 22; 16(10):923-930. PubMed ID: 31663477
    [Abstract] [Full Text] [Related]

  • 9. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M, Teng L, Wang Y, Zhang J, Sun X.
    Drug Deliv; 2016 May 22; 23(4):1420-5. PubMed ID: 26203688
    [Abstract] [Full Text] [Related]

  • 10. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG, Tagalpallewar AA, Kokare CR.
    AAPS PharmSciTech; 2019 Jan 02; 20(1):22. PubMed ID: 30604305
    [Abstract] [Full Text] [Related]

  • 11. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H, Geng D, Liu H, Li Z, Cao J.
    Drug Deliv; 2016 Nov 02; 23(9):3665-3673. PubMed ID: 27749102
    [Abstract] [Full Text] [Related]

  • 12. Mucoadhesive nanostructured lipid carriers (NLCs) as potential carriers for improving oral delivery of curcumin.
    Chanburee S, Tiyaboonchai W.
    Drug Dev Ind Pharm; 2017 Mar 02; 43(3):432-440. PubMed ID: 27808665
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS, Korabu SS, Ghodake VN.
    Colloids Surf B Biointerfaces; 2014 Apr 01; 116():81-7. PubMed ID: 24445002
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
    Emami J, Rezazadeh M, Sadeghi H, Khadivar K.
    Pharm Dev Technol; 2017 May 01; 22(3):370-382. PubMed ID: 27689412
    [Abstract] [Full Text] [Related]

  • 20. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S, Ng WK, Tan RB.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):139-51. PubMed ID: 22664358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.